Mary Wilson
Well-known member
Press release
From:UK Health Security Agency
Published 23 September 2022
Last updated 23 September 2022
The UK Health Security Agency (UKHSA) has announced that second doses of the smallpox (Jynneos) vaccine will be offered to people at highest risk from monkeypox, in order to maximise protection against the virus.
This targeted approach is also supported by modelling published in today’s technical briefing 8 which suggests vaccinating 25% of the groups most at risk could significantly reduce the risk of transmission.
Whilst sexual health clinics will continue to prioritise offering first doses to those at highest risk, some clinics will also begin to offer eligible people a second dose to provide longer term protection.
The Joint Committee on Vaccination and Immunisation (JCVI) has endorsed UKHSA’s proposal to offer second doses to those at highest risk, while continuing efforts to maximise uptake of the first dose within this group.
There are no current plans to widen the offer of vaccination beyond the existing priority cohorts, though this decision will be kept under review.
The NHS will call forward those that are eligible for vaccination. Second doses will be offered from around 2 to 3 months after the first dose to maximise protection. ...
https://www.gov.uk/government/news/...fered-to-those-at-highest-risk-from-monkeypox
From:UK Health Security Agency
Published 23 September 2022
Last updated 23 September 2022
The UK Health Security Agency (UKHSA) has announced that second doses of the smallpox (Jynneos) vaccine will be offered to people at highest risk from monkeypox, in order to maximise protection against the virus.
This targeted approach is also supported by modelling published in today’s technical briefing 8 which suggests vaccinating 25% of the groups most at risk could significantly reduce the risk of transmission.
Whilst sexual health clinics will continue to prioritise offering first doses to those at highest risk, some clinics will also begin to offer eligible people a second dose to provide longer term protection.
The Joint Committee on Vaccination and Immunisation (JCVI) has endorsed UKHSA’s proposal to offer second doses to those at highest risk, while continuing efforts to maximise uptake of the first dose within this group.
There are no current plans to widen the offer of vaccination beyond the existing priority cohorts, though this decision will be kept under review.
The NHS will call forward those that are eligible for vaccination. Second doses will be offered from around 2 to 3 months after the first dose to maximise protection. ...
https://www.gov.uk/government/news/...fered-to-those-at-highest-risk-from-monkeypox
